Acquisition synergies ARA recently announced its acquisition by Ephicacy Consulting Group, signaling potential for expanded services, larger client access, and cross-sell opportunities in biostatistics, data management, and regulatory support across pharmaceutical, biotech, and medical device sectors.

Expanded capacity With a revenue range of 10M-25M and a 11-50 employee base, there is room for growth through integrated projects, offering scalable biostatistical and data management solutions to larger programs or serial trials managed by Ephicacy and its client network.

Clinical trial footprint Having supported over 700 clinical trials across domestic and international settings positions the company as experienced in diverse therapeutic areas, enabling targeted upsell of advanced analytics, data management, and trial optimization services to sponsors seeking depth and reliability.

Technology leverage Utilization of a modern tech stack including WordPress, Adobe Experience Cloud, Shopify, Smartsheet and enterprise collaboration tools suggests readiness for digital workflows, client portals, and streamlined submission or e-sign workflows to improve project timing and stakeholder satisfaction.

Strategic partnership ARA emphasizes transparency, flexible resourcing, and strategic partnership to act as an extension of the client team, creating a value proposition for ongoing, long-term contracting and renewal opportunities with pharmaceutical, biotech, and medical device customers seeking reliable outsourcing partners.